SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GENOMIC VALLEY BIOTECH

BSE: 539206 29 Jun 2025
Healthcare
₹ 50
GENOMIC VALLEY BIOTECH LIMITED specializes in Biotechnology within the Healthcare sector.

GENOMIC VALLEY BIOTECH - Share Price & Details

Market Cap
₹14.8
High /Low
108.0 / 39.5
Stock P/E
41.0
Book Value
₹12.7
Dividend Yield
0.0
ROCE
11.8
ROE
₹9.68
Face Value
10.0
PEG Ratio
9.28
EVEBITDA
₹33.4
Debt
0.00
CMP / FCF
64.2
Debt to equity
₹0.0
NP Ann
0.36
High price all time
108.0
Piotroski score
₹7.0
Graham Number
18.4
No. Eq. Shares
0.31
Net CF
₹0.04
Net profit
0.36
Price to book value
3.8
Interest Coverage
₹NA
Low price all time
8.25
Industry PE
27.7
Reserves
₹0.84
Free Cash Flow
₹0.02

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
LOOKS HEALTH SERVICES LIMITEDNANANANA5.11256.0
Triochem Products Ltd.,NANANANA0
GENOMIC VALLEY BIOTECH LIMITEDNANANANA14.841.0
Span Divergent LimitedNANANANA11.815.0
DECIPHER LABS LIMITEDNANANANA11.4

Peer Comparison Chart


About GENOMIC VALLEY BIOTECH

GENOMIC VALLEY BIOTECH LIMITED, with Security Code 539206, is a leading player in the Biotechnology industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Bharat Biotech launches India’s only vertically integrated cell and gene therapy, viral production facility at Genome Valley

(06 Apr 2025)
Bharat Biotech International Limited (BBIL), a pioneer in affordable indigenous vaccine development and manufacturing, has announced the...
Read more →

Miltenyi Biotec inaugurates India’s first cell and gene therapy CoE in Hyderabad

(24 Feb 2025)
Miltenyi Biotec, a global leader in cell and gene therapy (CGT) solutions, has launched India's first-ever dedicated cell & gene therapy centre-of-excellence (...
Read more →

Q3 Results: RVNL, EaseMyTrip, MTNL, Aditya Birla Fashion And Others To Announce Earnings Today; Full List Here

(14 Feb 2025)
Nearly 700 companies are slated to announce their Q3 earnings on Friday, Feb. 14 as the trading week inches to its end.
Read more →

Genomic Valley Biotech Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024

(14 Dec 2024)
Genomic Valley Biotech Limited reported earnings results for the second quarter and six months ended September 30, 2024.
Read more →

Telangana secures over Rs 36,000 crore in life sciences investments, genome valley leads the way

(15 Nov 2024)
Telangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36000 crore was invested in the past year.
Read more →

Genomic Valley Standalone September 2024 Net Sales at Rs 0.21 crore, up 203.61% Y-o-Y

(21 Oct 2024)
Quarterly Net Profit at Rs. 0.15 crore in September 2024 up 535.78% from Rs. 0.02 crore in September 2023.
Read more →